Lianne Messchendorp

6PUBLICATIONS
31CO-AUTHORS
Innate immunityPlant pathologyMedical infection agents (incl. prions)Immunogenetics (incl. genetic immunology)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 08, 2026
Kidney Transplant Recipients Develop Nasal Mucosal Antibodies to SARS-CoV-2 With ACE2-Inhibiting Activity Following mRNA Vaccination.

|May 04, 2026
Unveiling Donor-Derived BKPyV DNAemia Through Analysis of Contralateral Kidney Transplant Recipients.

|Mar 03, 2026
Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patients.

Sophie C Frölke, Kenney G Amirkhan, Nelly van der Bom-Baylon

|Apr 15, 2025
Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial.

A Lianne Messchendorp, Luca M Zaeck, Pim Bouwmans

|Jan 23, 2024
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients.

A Lianne Messchendorp, Jan-Stephan F Sanders, Alferso C Abrahams

|Feb 15, 2023
Mycophenolic Acid Exposure Determines Antibody Formation Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study.

Soufian Meziyerh, Pim Bouwmans, Teun van Gelder

Pageof 1

Frequent Collaborators

4 joint publications

Luuk B Hilbrands

3 joint publications

Jan-Stephan S Sanders

3 joint publications

Pim Bouwmans

2 joint publications

Arjan D van Zuilen